Correlation Between ATyr Pharma, and NV Bekaert
Can any of the company-specific risk be diversified away by investing in both ATyr Pharma, and NV Bekaert at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATyr Pharma, and NV Bekaert into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between aTyr Pharma, and NV Bekaert SA, you can compare the effects of market volatilities on ATyr Pharma, and NV Bekaert and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATyr Pharma, with a short position of NV Bekaert. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATyr Pharma, and NV Bekaert.
Diversification Opportunities for ATyr Pharma, and NV Bekaert
-0.91 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ATyr and BEKAY is -0.91. Overlapping area represents the amount of risk that can be diversified away by holding aTyr Pharma, and NV Bekaert SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NV Bekaert SA and ATyr Pharma, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on aTyr Pharma, are associated (or correlated) with NV Bekaert. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NV Bekaert SA has no effect on the direction of ATyr Pharma, i.e., ATyr Pharma, and NV Bekaert go up and down completely randomly.
Pair Corralation between ATyr Pharma, and NV Bekaert
Given the investment horizon of 90 days aTyr Pharma, is expected to generate 1.41 times more return on investment than NV Bekaert. However, ATyr Pharma, is 1.41 times more volatile than NV Bekaert SA. It trades about 0.04 of its potential returns per unit of risk. NV Bekaert SA is currently generating about 0.02 per unit of risk. If you would invest 222.00 in aTyr Pharma, on September 3, 2024 and sell it today you would earn a total of 134.00 from holding aTyr Pharma, or generate 60.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 61.62% |
| Values | Daily Returns |
aTyr Pharma, vs. NV Bekaert SA
Performance |
| Timeline |
| aTyr Pharma, |
| NV Bekaert SA |
ATyr Pharma, and NV Bekaert Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ATyr Pharma, and NV Bekaert
The main advantage of trading using opposite ATyr Pharma, and NV Bekaert positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATyr Pharma, position performs unexpectedly, NV Bekaert can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NV Bekaert will offset losses from the drop in NV Bekaert's long position.| ATyr Pharma, vs. Ecoloclean Industrs | ATyr Pharma, vs. Ainsworth Game Technology | ATyr Pharma, vs. Old Republic International | ATyr Pharma, vs. Playstudios |
| NV Bekaert vs. Thyssenkrupp AG ON | NV Bekaert vs. Mueller Industries | NV Bekaert vs. Insteel Industries | NV Bekaert vs. Carpenter Technology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |